Progyny
Focus: Progyny is a fertility benefits and IVF product company focused on women's health, headquartered in New York with a specialized portfolio centered on the Eeva time-lapse imaging system for embryo selection.
Profile data last refreshed 19h ago · AI intelligence enriched 1mo ago
Open Jobs
27+12 this month
Growing — net +12 jobs in 30d
26 jobs added vs 14 removed. Steady team buildout.
Should You Work at Progyny?
AI assessmentProgyny offers a focused fertility-tech opportunity with public-market backing, but limited transparency on financials and modest hiring volume warrant careful due diligence before committing.
Why Work Here
- Publicly traded company (ticker PGNY) with recent positive analyst coverage from Goldman Sachs, signaling market confidence and potential for equity upside
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
10 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
In-vitro fertilization using Eeva
InfertilityClinical Trials (1)
NCT01816802Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment
N/AHelp build intelligence for Progyny
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.